EUDA Health Holdings Limited (NASDAQ:EUDA) Short Interest Down 38.7% in June

EUDA Health Holdings Limited (NASDAQ:EUDA) was the target of a large decline in short interest during the month of June. As of June 30th, there was short interest totaling 3,202 shares, a decline of 38.7% from the June 15th total of 5,223 shares. Based on an average daily volume of 5,978 shares, the short-interest ratio is presently 0.5 days. Approximately 0.1% of the company’s stock are short sold.

Analyst Ratings Changes

EUDA has been the subject of a number of recent research reports. Weiss Ratings cut shares of EUDA Health from a “sell (d)” rating to a “sell (e+)” rating in a report on Friday, May 8th. Zacks Research upgraded shares of EUDA Health from a “strong sell” rating to a “hold” rating in a research note on Friday, May 8th. One research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $55.00.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in EUDA Health stock. Jane Street Group LLC acquired a new position in EUDA Health Holdings Limited (NASDAQ:EUDA) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 25,675 shares of the company’s stock, valued at approximately $59,000. Jane Street Group LLC owned about 0.07% of EUDA Health at the end of the most recent quarter. 4.35% of the stock is currently owned by institutional investors and hedge funds.

EUDA Health Stock Up 4.5%

Shares of NASDAQ:EUDA opened at $11.68 on Thursday. The stock’s 50-day moving average is $15.07 and its 200-day moving average is $18.50. EUDA Health has a 52-week low of $5.26 and a 52-week high of $86.00.

EUDA Health (NASDAQ:EUDA) last posted its quarterly earnings data on Tuesday, May 5th. The company reported ($0.44) earnings per share for the quarter, topping the consensus estimate of ($1.20) by $0.76. The business had revenue of $1.92 million for the quarter, compared to analyst estimates of $3.90 million. On average, analysts expect that EUDA Health will post 1.6 earnings per share for the current year.

About EUDA Health

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.